Former X CEO Linda Yaccarino said Tuesday she has taken on a new role leading a digital health platform, less than a month after announcing her departure from Elon Musk’s social media platform.
Yaccarino is joining eMed Population Health, which provides support for patients on GLP-1 medications, as CEO.
“Our mission is revolutionizing how people receive safe, effective care for chronic condition management through GLP-1 therapies, while building the programs and technologies needed to sustain lasting health outcomes,” she wrote in a post on X.
“This is truly a transformational moment in preventative healthcare, and I’m energized by the opportunity to help lead what could become the most impactful health initiative of our time,” she continued.
Yaccarino spent two years as CEO of X following Musk’s acquisition of the platform then known as Twitter in 2022. She joined the company about six months after the tech mogul’s takeover, leaving her role at NBCUniversal Media as chair of global advertising and partnerships.
Her tenure at the social media platform was marked by upheaval and crises as Musk repeatedly alienated advertisers and made numerous controversial changes, including rebranding the site as X.
She announced her plans to leave the company in early July, saying she was “immensely grateful to [Musk] for entrusting me with the responsibility of protecting free speech, turning the company around, and transforming X into the Everything App.”
